ICPT
Intercept Pharmaceuticals, Inc.
ICPT
ICPT
Delisted
ICPT was delisted on the 7th of November, 2023.
143 hedge funds and large institutions have $384M invested in Intercept Pharmaceuticals, Inc. in 2023 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 54 increasing their positions, 42 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
17% less call options, than puts
Call options by funds: $10.1M | Put options by funds: $12.1M
Holders
143
Holding in Top 10
–
Calls
$10.1M
Puts
$12.1M
Top Buyers
| 1 | +$6.02M | |
| 2 | +$5.89M | |
| 3 | +$4.87M | |
| 4 |
Renaissance Technologies
New York
|
+$4.59M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4M |
Top Sellers
| 1 | -$6.54M | |
| 2 | -$6.09M | |
| 3 | -$5.43M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$4.5M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$4.26M |